NDC 51407-680-11 - Rizatriptan Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51407-680
- Requested NDC
- 51407-680-11
- Package NDCs from labels
- 51407-680-06, 51407-680-18, 51407-680-11, 51407-680-03
- Manufacturer
- Golden State Medical Supply, Inc. | Aurobindo Pharma Limited
- Effective date
- 2025-08-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ASPARTAME - Golden State Medical Supply, Inc. | Aurobindo Pharma Limited | Golden State Medical Supply, Inc. | Aurobindo Pharma Limited | 2025-08-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51407-680-03 | Rizatriptan Benzoate | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 3 | |
| 51407-680-06 | Rizatriptan Benzoate | 6 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 6 | 3 | |
| 51407-680-11 | Rizatriptan Benzoate | 3 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 3 | 3 | |
| 51407-680-18 | Rizatriptan Benzoate | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| rizatriptan benzoate | RIZATRIPTAN BENZOATE | Glenmark Pharmaceuticals Inc., USA | 4de33a24-db69-444a-b04d-c69ccba57ab2 | 2026-10-09 | Warnings, Adverse reactions | 312837 312839 WR978S7QHH |
| rizatriptan benzoate | RIZATRIPTAN BENZOATE | Glenmark Pharmaceuticals Inc., USA | 99c66300-bd75-4b31-9fab-88c6e4b12688 | 2026-10-09 | Warnings, Adverse reactions | WR978S7QHH |
| SYMBRAVO | MELOXICAM, RIZATRIPTAN | Axsome Therapeutics, Inc. | dcf1ecd1-08a0-8e47-e053-2a95a90abdc7 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | WR978S7QHH |
| SIANG PUREOIL FORMULA I | MENTHOL, PEPPERMINT, CAMPHOR, CLOVE, CINNAMON | BERTRAM (1958) COMPANY LIMITED | 14e1b199-8f2e-4e65-8d07-98c780d584ed | 2026-10-06 | Warnings | V95R5KMY2B |
| SIANG PUREOIL FORMULA II 5mL | MENTHOL, PEPPERMINT, CAMPHOR, CLOVE, CINNAMON OIL | BERTRAM (1958) COMPANY LIMITED | a4633539-935b-4204-a87d-dde803ebbef4 | 2026-09-19 | Warnings | V95R5KMY2B |
| SIANG PUREOIL FORMULA I 5mL | MENTHOL, PEPPERMINT, CAMPHOR, CLOVE, CINNAMON OIL | BERTRAM (1958) COMPANY LIMITED | 961e4331-97aa-42df-be42-dff2e41f894d | 2026-09-19 | Warnings | V95R5KMY2B |
| SIANG PUREOIL FORMULA I 3mL | MENTHOL, PEPPERMINT, CAMPHOR, CLOVE, CINNAMON OIL | BERTRAM (1958) COMPANY LIMITED | 9db4c0f9-263a-4556-8b91-03fa8a4775d8 | 2026-09-19 | Warnings | V95R5KMY2B |
| SIANG PUREOIL FORMULA II 3mL | MENTHOL, PEPPERMINT, CAMPHOR, CLOVE, CINNAMON OIL | BERTRAM (1958) COMPANY LIMITED | a7d8aa1e-fab6-4aaa-8c51-313e0fc9b652 | 2026-09-19 | Warnings | V95R5KMY2B |
| Rizatriptan benzoate | RIZATRIPTAN BENZOATE | Chartwell RX, LLC | faf3bc1d-8818-47b0-8ad1-80bfbf40ab78 | 2026-09-13 | Warnings, Adverse reactions | 312837 312839 WR978S7QHH |
| SIANG PUREOIL FORMULA II 25 CC | MENTHOL, PEPPERMINT, CAMPHOR, CLOVE, CINNAMON | BERTRAM (1958) COMPANY LIMITED | 5b3c7086-1907-9270-e063-6394a90ad100 | 2026-09-11 | Warnings | V95R5KMY2B |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | REMEDYREPACK INC. | 1e547fac-a9e5-4c7b-adba-4e6b75141183 | 2026-09-08 | Warnings, Adverse reactions | ANDA203062 312837 WR978S7QHH |
| RIZAFILM | RIZATRIPTAN BENZOATE | A-S Medication Solutions | 8e36b946-cf2a-44d9-9ba7-4385cfe6b360 | 2026-08-28 | Warnings, Adverse reactions | WR978S7QHH |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | DIRECT RX | 673d584c-0691-d2fb-e053-2991aa0a7797 | 2026-03-17 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Direct_Rx | f754388d-77f1-0d8d-e053-6394a90a7b7e | 2026-03-17 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate ODT | RIZATRIPTAN BENZOATE ODT | Direct_rx | 2c29e066-c018-22e7-e063-6294a90a035c | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | 312837 WR978S7QHH |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | direct rx | b3d981bc-3c9e-8a9e-e053-2995a90a8f65 | 2026-03-05 | Warnings, Adverse reactions | WR978S7QHH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.